Endo Int'l (ENDP) Tops Q4 EPS by 4c; Guides FY15 EPS, Revs Below Expectations

Endo Int'l (NASDAQ: ENDP) reported Q4 EPS of $1.16, $0.04 better than the analyst estimate of $1.12. Revenue for the quarter came in at $800 million versus the consensus estimate of $780.44 million.

Endo Int'l sees FY2015 EPS of $4.35-$4.55, versus the consensus of $4.88. Endo Int'l sees FY2015 revenue of $2.90-3.0 billion, versus the consensus of $3.47 billion.

For earnings history and earnings-related data on Endo Int'l (ENDP) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c
• Traws Pharma (TRAW) Tops Q2 EPS by 27c